Developer docs
API playgroundTry for free, no card

Search company profiles

EFOR

Full company profile

uuid000mj3b

Namestring
EFOR
Legal namestring
Efor Group
Websiteurl
efor-group.fr
Company typeenum
Private
Founded yearint
2007
Descriptiontext

Efor Group is a France-based professional services firm specializing in quality and compliance for the life sciences industry, headquartered in Lyon and operating across 18 countries with approximately 3,200 employees and reported revenues of €375+ million. The company delivers an integrated suite of services built around Commissioning, Qualification & Validation (CQV), Computer System Validation (CSV), Digital Validation, Quality Management, Engineering, Regulatory Affairs, Clinical Research Organization (CRO) services, Audit, and Training. Its stated client base covers approximately 90% of top pharmaceutical companies, with particular emphasis on breakthrough therapy subsegments such as GLP-1, oncology, and cell and gene therapy manufacturing.

The firm operates on a project-based, custom enterprise engagement model with multi-year contracts and quote-based pricing tailored to client scope. Its go-to-market is enterprise field sales targeting large multinational pharmaceutical and biotechnology manufacturers, supported by content marketing, technical publications, and industry events. Service delivery increasingly incorporates AI-enabled tools and a Digital Validation Platform intended to integrate with traditional CQV/CSV services, accelerate time-to-market, and strengthen compliance.

Efor's growth has been driven by a combination of organic expansion and targeted acquisitions. In March 2026, the company acquired DynamixE (U.S.) to gain immediate access to the world's largest life sciences consulting market — boosting U.S. revenue to nearly $60 million — and No Deviation (Singapore) to add over 300 professionals and an established operational base in Shanghai. The company competes in a global life sciences consulting market sized at $34 billion, growing at roughly 9% annually, with the U.S. representing over 50% of that opportunity.

Short descriptiontext

Efor Group is a France-based professional services firm delivering quality and compliance consulting — including CQV, CSV, digital validation, and quality management — to life sciences companies across 18 countries, serving roughly 90% of top pharmaceutical manufacturers worldwide.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersCaluire, France
HQ citystring
Caluire
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
quality compliance consulting, commissioning qualification validation, life sciences consulting, computer system validation, regulatory affairs services
Industry1 code
PRIMARYHLAGAOAA
Clinical Operations & Monitoring FSP (CRA/CTM/Start-up)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)
NAICS code2 codes
  • Other Scientific and Technical Consulting Services54169
  • Other Computer Related Services541519
SIC code2 codes
  • Services-Engineering, Accounting, Research, Management8700
  • Services-Engineering Services8711
Product category
Life Sciences Quality & Compliance Consulting
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Quality and Compliance Professional Services
TypeProfessional Services
Description

Professional services revenue from CQV (Commissioning, Qualification & Validation), CSV (Computer System Validation), Quality Management, and related consulting services delivered to life sciences companies globally

efor-group.com
2North American Operations
TypeProfessional Services
Description

Revenue generated from U.S. operations including biopharmaceutical manufacturing services, process engineering, and digitalization. North American operations generate nearly $60 million in revenue out of approximately $400 million worldwide

pulse2.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Pricing details1 tier
1Custom enterprise engagement
ModelOtherBilling cadenceMulti-year contract
Notes

Services delivered on a project basis with scope, timeline, and pricing tailored to individual client engagements. No standard pricing tiers publicly available.

efor-group.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

EFOR is a global quality and compliance consulting firm serving the life sciences industry. The company delivers CQV (Commissioning, Qualification & Validation), CSV (Computer System Validation), Digital Validation, Quality Management, Engineering, Regulatory Affairs, Audit, Training, and CRO services to pharmaceutical and biotechnology companies across 18 countries. Leveraging AI-enabled tools and digital solutions, EFOR helps clients embed regulatory compliance into their manufacturing operations and accelerate time-to-market for breakthrough therapies.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 90% of top pharmaceutical companies served as clients
+2 more records
Product overview1 text field

Efor is a global leader in quality and compliance for the Life Sciences industry, offering an integrated suite of professional services organized around CQV (Commissioning, Qualification & Validation), CSV (Computer System Validation), Digital Validation, Quality Management, Engineering, Regulatory Affairs, CRO, Audit, and Training. The company combines worldwide reach with deep local capability, implementing CQV & CSV delivery, quality management and process industrialization to ongoing manufacturing excellence across global sites. Efor leverages AI-enabled tools and advanced digital solutions, bringing together rigorous technical know-how, scalable delivery models, and AI-enabled tools to help clients navigate the most complex regulatory environments. Operating across 18 countries with 375+ million euros in revenues and 3,200 employees, Efor supports companies at every stage with strong project management and project controls expertise, serving 90% of top pharmaceutical companies worldwide.

Product and service10 records
1CQV (Commissioning, Qualification & Validation)
CategoryCore service
Description

Comprehensive CQV services ensuring equipment, facilities, and systems meet regulatory requirements and operational specifications for life sciences manufacturing.

2CSV (Computer System Validation)
CategoryCore service
Description

Validation services for computerized systems ensuring compliance with regulatory standards (e.g., GAMP, 21 CFR Part 11) in regulated life sciences environments.

3Digital Validation
CategoryCore service
Description

AI-enabled digital validation solutions leveraging advanced technologies to modernize and accelerate validation processes for life sciences compliance.

4Quality Management
CategoryCore service
Description

Quality management services helping life sciences companies maintain cGMP compliance and operational excellence across global manufacturing sites.

5Engineering
CategoryComplementary service
Description

Engineering services supporting life sciences manufacturing operations and infrastructure, including strong project management and project controls expertise.

6Regulatory Affairs
CategoryComplementary service
Description

Regulatory affairs consulting to help life sciences clients navigate complex multi-jurisdiction regulatory environments and ensure market compliance for drugs and health products.

7CRO (Clinical Research Organization)
CategoryComplementary service
Description

Clinical research services supporting drug development and clinical trials across the life sciences ecosystem.

8Audit
CategoryComplementary service
Description

Audit services for compliance verification and quality assurance across life sciences operations, including GMP audits and supplier qualification.

9Training
CategoryComplementary service
Description

Training services for life sciences professionals covering compliance, quality, regulatory, and technical topics to upskill internal teams.

10AI & Advanced Technologies
CategoryCore service
Description

AI-enabled tools and digital solutions that accelerate time-to-market, strengthen compliance, and boost operational efficiency for life sciences companies.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-03-05
Description

Acquisition of Singapore-based No Deviation, a Life Sciences services company specializing in CQV, CSV, Quality Compliance, and Digital Enablement. Founded in 2007, No Deviation operates across Singapore, China, and Ireland with a team of approximately 30-100 professionals. The acquisition reinforces Efor's presence in Asia with over 300 professionals regionally, providing an established operational base in Shanghai and direct access to key industrial stakeholders in China.

2DynamixE, Inc.
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-03-02
Description

Acquisition of U.S.-based DynamixE, Inc., a specialized firm in biopharmaceutical manufacturing services including CQV, process engineering, and digitalization. Founded in New York in 2017, DynamixE operates across major U.S. life sciences hubs including North Carolina, Massachusetts, California, Texas, New Jersey, and Pennsylvania, specializing in biologics and cell and gene therapy biomanufacturing environments. The acquisition immediately boosts Efor's U.S. revenue to nearly $60 million and positions the company in the world's largest life sciences market.

briefglance.com
Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Azzur Group is a U.S.-based life sciences consulting and CQV/validation services firm serving pharma and biotech manufacturers. It is one of the most direct U.S. competitors in CQV, CSV and quality management that EFOR now faces through its DynamixE acquisition.

TypeDirect peer
Description

PharmaLex (now part of Cencora/PharmaLex) is a specialist regulatory, quality and compliance consulting firm serving life sciences. It is one of the closest direct comparables to EFOR's regulatory affairs and quality management practices in terms of focus and customer base.

TypeBroad incumbent
Description

ICON is a top-3 global CRO and life sciences services firm with growing consulting, labs and decentralized clinical capabilities. It overlaps with EFOR's CRO and regulatory/quality practices and competes for the same top-pharma enterprise contracts.

4KCR
TypeDirect peer
Description

KCR is a clinical research and consulting services provider for life sciences, with capabilities across CRO, regulatory and quality. It is a mid-sized European-rooted peer comparable to EFOR in scale and service breadth.

TypeDirect peer
Description

Tunnell Consulting is a U.S. life sciences management consulting firm focused on pharma manufacturing, quality and operational excellence. It targets the same top-pharma enterprise buyer set as EFOR with a similar services-led model.

TypeBroad incumbent
Description

IQVIA is the largest global life sciences services company, offering clinical, consulting, technology and compliance/quality services to pharma and biotech. It is the broadest incumbent competing across many of EFOR's service lines at significantly larger scale.

TypeBroad incumbent
Description

Parexel is a global CRO with biopharmaceutical development, regulatory and consulting services. It competes with EFOR for CRO, regulatory affairs and quality compliance engagements with top pharma clients.

TypeBroad incumbent
Description

Labcorp's Drug Development segment offers CRO and central lab services to pharma and biotech, competing with EFOR's CRO and broader life sciences services portfolio at much larger scale.

TypeDirect peer
Description

CAI is a global CQV, engineering and compliance services firm dedicated to regulated life sciences manufacturing. It competes head-to-head with EFOR on commissioning, qualification and validation projects for pharma and biotech manufacturers.

TypeBroad incumbent
Description

Charles River provides life sciences research, manufacturing support and CDMO services to pharma and biotech. Its Manufacturing Solutions segment directly overlaps EFOR's CQV, validation and biomanufacturing quality offerings.

Market position
Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks1 record

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

EFOR

Life Sciences Quality & Compliance Consultingefor-group.fr

Efor Group is a France-based professional services firm delivering quality and compliance consulting — including CQV, CSV, digital validation, and quality management — to life sciences companies across 18 countries, serving roughly 90% of top pharmaceutical manufacturers worldwide.

What EFOR does

Efor Group is a France-based professional services firm specializing in quality and compliance for the life sciences industry, headquartered in Lyon and operating across 18 countries with approximately 3,200 employees and reported revenues of €375+ million. The company delivers an integrated suite of services built around Commissioning, Qualification & Validation (CQV), Computer System Validation (CSV), Digital Validation, Quality Management, Engineering, Regulatory Affairs, Clinical Research Organization (CRO) services, Audit, and Training. Its stated client base covers approximately 90% of top pharmaceutical companies, with particular emphasis on breakthrough therapy subsegments such as GLP-1, oncology, and cell and gene therapy manufacturing.

The firm operates on a project-based, custom enterprise engagement model with multi-year contracts and quote-based pricing tailored to client scope. Its go-to-market is enterprise field sales targeting large multinational pharmaceutical and biotechnology manufacturers, supported by content marketing, technical publications, and industry events. Service delivery increasingly incorporates AI-enabled tools and a Digital Validation Platform intended to integrate with traditional CQV/CSV services, accelerate time-to-market, and strengthen compliance.

Efor's growth has been driven by a combination of organic expansion and targeted acquisitions. In March 2026, the company acquired DynamixE (U.S.) to gain immediate access to the world's largest life sciences consulting market — boosting U.S. revenue to nearly $60 million — and No Deviation (Singapore) to add over 300 professionals and an established operational base in Shanghai. The company competes in a global life sciences consulting market sized at $34 billion, growing at roughly 9% annually, with the U.S. representing over 50% of that opportunity.

EFOR firmographics

Firmographics
Name
EFOR
Legal name
Efor Group
Website
https://efor-group.fr
Company type
Private
Founded year
2007
Operating status
Operating
Headcount range
1,001–5,000 employees
Short description
Efor Group is a France-based professional services firm delivering quality and compliance consulting — including CQV, CSV, digital validation, and quality management — to life sciences companies across 18 countries, serving roughly 90% of top pharmaceutical manufacturers worldwide.
Ownership category
akta.pro rank

EFOR industry classification

Industry
Product category
Life Sciences Quality & Compliance Consulting
NAICS
Other Scientific and Technical Consulting Services (54169), Other Computer Related Services (541519)
SIC
Services-Engineering, Accounting, Research, Management (8700), Services-Engineering Services (8711)
akta.pro industry
PRIMARYHLAGAOAA
Clinical Operations & Monitoring FSP (CRA/CTM/Start-up)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)

Keywords

  • Quality compliance consulting
  • Commissioning qualification validation
  • Life sciences consulting
  • Computer system validation
  • Regulatory affairs services

Where EFOR is headquartered

Location

Headquarters

HQ city
Caluire
HQ country
France
HQ region
Europe

Offices3 records

Markets served

EFOR business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Quality and Compliance Professional Services: Professional services revenue from CQV (Commissioning, Qualification & Validation), CSV (Computer System Validation), Quality Management, and related consulting services delivered to life sciences companies globally
  2. North American Operations: Revenue generated from U.S. operations including biopharmaceutical manufacturing services, process engineering, and digitalization. North American operations generate nearly $60 million in revenue out of approximately $400 million worldwide

Pricing tiers

ModelBillingPrice
OtherMulti-year contractCustom enterprise engagement

Go-to-market motion2 records

Distribution channels1 record

Marketing channels5 records

EFOR product offering

Product offering

Core offering

EFOR is a global quality and compliance consulting firm serving the life sciences industry. The company delivers CQV (Commissioning, Qualification & Validation), CSV (Computer System Validation), Digital Validation, Quality Management, Engineering, Regulatory Affairs, Audit, Training, and CRO services to pharmaceutical and biotechnology companies across 18 countries. Leveraging AI-enabled tools and digital solutions, EFOR helps clients embed regulatory compliance into their manufacturing operations and accelerate time-to-market for breakthrough therapies.

Product overview

Efor is a global leader in quality and compliance for the Life Sciences industry, offering an integrated suite of professional services organized around CQV (Commissioning, Qualification & Validation), CSV (Computer System Validation), Digital Validation, Quality Management, Engineering, Regulatory Affairs, CRO, Audit, and Training. The company combines worldwide reach with deep local capability, implementing CQV & CSV delivery, quality management and process industrialization to ongoing manufacturing excellence across global sites. Efor leverages AI-enabled tools and advanced digital solutions, bringing together rigorous technical know-how, scalable delivery models, and AI-enabled tools to help clients navigate the most complex regulatory environments. Operating across 18 countries with 375+ million euros in revenues and 3,200 employees, Efor supports companies at every stage with strong project management and project controls expertise, serving 90% of top pharmaceutical companies worldwide.

Differentiator

Problem solved

Functional benefit

Products and services

  • CQV (Commissioning, Qualification & Validation) Comprehensive CQV services ensuring equipment, facilities, and systems meet regulatory requirements and operational specifications for life sciences manufacturing.
  • CSV (Computer System Validation) Validation services for computerized systems ensuring compliance with regulatory standards (e.g., GAMP, 21 CFR Part 11) in regulated life sciences environments.
  • Digital Validation AI-enabled digital validation solutions leveraging advanced technologies to modernize and accelerate validation processes for life sciences compliance.
  • Quality Management Quality management services helping life sciences companies maintain cGMP compliance and operational excellence across global manufacturing sites.
  • Engineering Engineering services supporting life sciences manufacturing operations and infrastructure, including strong project management and project controls expertise.
  • Regulatory Affairs Regulatory affairs consulting to help life sciences clients navigate complex multi-jurisdiction regulatory environments and ensure market compliance for drugs and health products.
  • CRO (Clinical Research Organization) Clinical research services supporting drug development and clinical trials across the life sciences ecosystem.
  • Audit Audit services for compliance verification and quality assurance across life sciences operations, including GMP audits and supplier qualification.
  • Training Training services for life sciences professionals covering compliance, quality, regulatory, and technical topics to upskill internal teams.
  • AI & Advanced Technologies AI-enabled tools and digital solutions that accelerate time-to-market, strengthen compliance, and boost operational efficiency for life sciences companies.

Quantifiable outcome

  • 90% of top pharmaceutical companies served as clients
  • +2 more outcomes

Companies that use EFOR

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles2 records

EFOR technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature2 records

EFOR partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • No DeviationcoreStrategic or Co-development Partner · 5 March 2026Acquisition of Singapore-based No Deviation, a Life Sciences services company specializing in CQV, CSV, Quality Compliance, and Digital Enablement. Founded in 2007, No Deviation operates across Singapore, China, and Ireland with a team of approximately 30-100 professionals. The acquisition reinforces Efor's presence in Asia with over 300 professionals regionally, providing an established operational base in Shanghai and direct access to key industrial stakeholders in China.
  • DynamixE, Inc.coreStrategic or Co-development Partner · 2 March 2026Acquisition of U.S.-based DynamixE, Inc., a specialized firm in biopharmaceutical manufacturing services including CQV, process engineering, and digitalization. Founded in New York in 2017, DynamixE operates across major U.S. life sciences hubs including North Carolina, Massachusetts, California, Texas, New Jersey, and Pennsylvania, specializing in biologics and cell and gene therapy biomanufacturing environments. The acquisition immediately boosts Efor's U.S. revenue to nearly $60 million and positions the company in the world's largest life sciences market.

Scale indicators8 records

Recent moves5 records

Expansion highlights5 records

EFOR competitors and assessment

Company assessment

Direct peers

  • Azzur Group: Azzur Group is a U.S.-based life sciences consulting and CQV/validation services firm serving pharma and biotech manufacturers. It is one of the most direct U.S. competitors in CQV, CSV and quality management that EFOR now faces through its DynamixE acquisition.
  • PharmaLex: PharmaLex (now part of Cencora/PharmaLex) is a specialist regulatory, quality and compliance consulting firm serving life sciences. It is one of the closest direct comparables to EFOR's regulatory affairs and quality management practices in terms of focus and customer base.
  • KCR: KCR is a clinical research and consulting services provider for life sciences, with capabilities across CRO, regulatory and quality. It is a mid-sized European-rooted peer comparable to EFOR in scale and service breadth.
  • Tunnell Consulting: Tunnell Consulting is a U.S. life sciences management consulting firm focused on pharma manufacturing, quality and operational excellence. It targets the same top-pharma enterprise buyer set as EFOR with a similar services-led model.
  • Commissioning Agents Inc. (CAI): CAI is a global CQV, engineering and compliance services firm dedicated to regulated life sciences manufacturing. It competes head-to-head with EFOR on commissioning, qualification and validation projects for pharma and biotech manufacturers.

Broad incumbents

  • ICON plc: ICON is a top-3 global CRO and life sciences services firm with growing consulting, labs and decentralized clinical capabilities. It overlaps with EFOR's CRO and regulatory/quality practices and competes for the same top-pharma enterprise contracts.
  • IQVIA: IQVIA is the largest global life sciences services company, offering clinical, consulting, technology and compliance/quality services to pharma and biotech. It is the broadest incumbent competing across many of EFOR's service lines at significantly larger scale.
  • Parexel: Parexel is a global CRO with biopharmaceutical development, regulatory and consulting services. It competes with EFOR for CRO, regulatory affairs and quality compliance engagements with top pharma clients.
  • Labcorp Drug Development (formerly Covance): Labcorp's Drug Development segment offers CRO and central lab services to pharma and biotech, competing with EFOR's CRO and broader life sciences services portfolio at much larger scale.
  • Charles River Laboratories: Charles River provides life sciences research, manufacturing support and CDMO services to pharma and biotech. Its Manufacturing Solutions segment directly overlaps EFOR's CQV, validation and biomanufacturing quality offerings.

Market position

Weaknesses5 records

Competitive moat4 records

Key risks1 record

Key highlights7 records

Customer concentration

EFOR social profiles

Digital presence

EFOR financial estimates

Financial estimate

Revenue estimate

Valuation estimate

EFOR leadership team

Management profile

Number of profiles

EFOR subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

EFOR funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

EFOR M&A and investment

M&A and investment

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about EFOR

What does EFOR do?

EFOR is a global quality and compliance consulting firm serving the life sciences industry. The company delivers CQV (Commissioning, Qualification & Validation), CSV (Computer System Validation), Digital Validation, Quality Management, Engineering, Regulatory Affairs, Audit, Training, and CRO services to pharmaceutical and biotechnology companies across 18 countries. Leveraging AI-enabled tools and digital solutions, EFOR helps clients embed regulatory compliance into their manufacturing operations and accelerate time-to-market for breakthrough therapies.

Is EFOR a public or private company?

EFOR is a private company. It is classified as unknown and is currently operating.

When was EFOR founded?

EFOR was founded in 2007. It employs 1,001 to 5,000 people.

Where is EFOR based?

EFOR is headquartered in Caluire, France, in the Europe region.

How does EFOR make money?

Two revenue lines are on record. Quality and Compliance Professional Services are the primary driver. The others are north American Operations.

Who are EFOR's main competitors?

Direct peers on record are Azzur Group, PharmaLex, KCR, Tunnell Consulting and Commissioning Agents Inc. (CAI). Broad incumbents are ICON plc, IQVIA, Parexel, Labcorp Drug Development (formerly Covance) and Charles River Laboratories.

Does EFOR have an API?

No public API is recorded for EFOR.

What industry is EFOR in?

EFOR's product category is Life Sciences Quality & Compliance Consulting. Its primary akta.pro industry code is HLAGAOAA, Clinical Operations & Monitoring FSP (CRA/CTM/Start-up). Its NAICS code is 54169 and its SIC code is 8700.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Australian Associated PressEfor strengthens its presence in Asia with the acquisition of No deviationEfor, a Lyon-based global quality and compliance services provider for the Life Sciences industry, has acquired Singapore-headquartered No deviation, a company specializing in Commissioning, Qualification & Validation (CQV), Computer System Validation (CSV), and Quality Compliance services. No deviation, founded in 2007, operates across Singapore, China, and Ireland, with approximately 100 professionals across its Asian operations. The acquisition brings Efor's Asian workforce to over 300 professionals and positions the group as a leading quality and compliance player across key Asian markets, reinforcing Efor's global expansion strategy combining organic growth with targeted acquisitions.PR NewswireEfor strengthens its presence in Asia with the acquisition of No deviationEfor, a Lyon-based global leader in quality and compliance for the Life Sciences industry, has completed the acquisition of Singapore-based No deviation, a company specializing in Commissioning, Qualification & Validation (CQV), Computer System Validation (CSV), and Quality Compliance services. The acquisition brings No deviation's operations in Singapore, China, and Ireland under Efor's umbrella, expanding the group to over 300 professionals across the Asian region. This deal reinforces Efor's global expansion strategy, combining organic growth with targeted acquisitions to position the company as a leading quality and compliance player in key Asian Life Sciences markets.Pulse 2.0Efor: Life Sciences Quality And Compliance Firm Acquires DynamixE To Expand U.S. CQV CapabilitiesEfor, a France-based quality and compliance specialist for the life sciences industry, has acquired DynamixE, a U.S.-based commissioning, qualification, and validation (CQV) firm serving pharmaceutical and biotechnology companies. The acquisition, the financial terms of which were not disclosed, strengthens Efor's North American operations, which now generate nearly $60 million in revenue out of approximately $400 million worldwide. DynamixE, founded in New York in 2017, operates across major U.S. life sciences hubs including North Carolina, Massachusetts, California, Texas, New Jersey, and Pennsylvania, and specializes in biologics and cell and gene therapy biomanufacturing environments.PR NewswireEfor strengthens its North American presence with the acquisition of DynamixEEfor, a France-based global leader in quality and compliance for Life Sciences industries, announced the acquisition of U.S.-based DynamixE, Inc., a company specializing in Commissioning, Qualification & Validation (CQV), process engineering, automation and digitalization for pharmaceutical and biotechnology sectors. DynamixE, founded in New York in 2017, has established operations across major U.S. life sciences hubs including North Carolina, Massachusetts, California, Texas, New Jersey, and Pennsylvania. The acquisition strengthens Efor's CQV capabilities in the U.S. market, where the company currently generates nearly $60 million in revenue out of approximately $400 million worldwide, supporting its continued North American expansion strategy.BriefglanceEfor Acquires DynamixE, Fortifying US Life Sciences Compliance GripFrench life sciences consulting company Efor has acquired U.S.-based DynamixE, Inc., a specialized firm in biopharmaceutical manufacturing services including commissioning, qualification, validation (CQV), process engineering, and digitalization. The acquisition immediately boosts Efor's U.S. revenue to nearly $60 million and positions the company in the world's largest life sciences market, which accounts for over 50% of the $34 billion global life sciences consulting market projected to grow at 9% annually. The deal reflects a broader consolidation trend in the life sciences services sector as companies seek scale, specialized expertise, and geographic reach to meet increasing regulatory complexity and digitalization demands.